This trial is testing a new drug compared to placebo (a "sugar pill" with no medicine) to see if it can help people with a certain heart condition.
2 Primary · 11 Secondary · Reporting Duration: Baseline up to Week 140
Experimental Treatment
Non-Treatment Group
1400 Total Participants · 3 Treatment Groups
Primary Treatment: AKCEA-TTR-LRx · Has Placebo Group · Phase 3
Age 18 - 90 · All Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: